Search Results - "de Weijert, Mirjam C. A."

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia by Arends, Tom J. H., Falke, Johannes, Lammers, Rianne J. M., Somford, Diederik M., Hendriks, Jan C. M., de Weijert, Mirjam C. A., Arentsen, Harm C., van der Heijden, Antoine G., Oosterwijk, Egbert, Alfred Witjes, J.

“…Objectives To explore whether urinary cytokine and chemokine (CK) levels differed between cold mitomycin-C (cold-MMC)-treated patients and chemohyperthermia…”
Get full text

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC by Oosterwijk-Wakka, Jeannette C, de Weijert, Mirjam C.A, Franssen, Gerben M, Leenders, William P.J, van der Laak, Jeroen A.W.M, Boerman, Otto C, Mulders, Peter F.A, Oosterwijk, Egbert

“…Abstract Anti-angiogenic treatment with tyrosine kinase inhibitors (TKI) has lead to an impressive increase in progression-free survival for patients with…”
Get full text

Strict regulation of CAIXg250/mn by HIF-1α in clear cell renal cell carcinoma by GRABMAIER, Karin, DE WEIJERT, Mirjam C. A, VERHAEGH, Gerald W, SCHALKEN, Jack A, OOSTERWIJK, Egbert

“…Renal cell carcinoma of the clear cell type (ccRCC) is associated with loss of functional von Hippel–Lindau (VHL) protein and high, homogeneous expression of…”
Get full text

Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer by Oosterwijk-Wakka, Jeannette C., de Weijert, Mirjam C.A., Franssen, Gerben M., Kolev, Dimitar R., de Haan, Ton A.F.J., Boerman, Otto C., Mulders, Peter F.A., Oosterwijk, Egbert

“…Sunitinib is an effective treatment for patients with metastatic Renal Cell Carcinoma (mRCC) but ultimately resistance occurs. The aim of this study was to…”
Get full text

Tyrosine Kinase Inhibitor Sorafenib Decreases 111 In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma by Muselaers, Constantijn H.J., Stillebroer, Alexander B., Desar, Ingrid M.E., Boers-Sonderen, Marye J., van Herpen, Carla M.L., de Weijert, Mirjam C.A., Langenhuijsen, Johan F., Oosterwijk, Egbert, Leenders, William P.J., Boerman, Otto C., Mulders, Peter F.A., Oyen, Wim J.G.

Get full text

Tyrosine Kinase Inhibitor Sorafenib Decreases ^sup 111^In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma by Muselaers, Constantijn HJ, Stillebroer, Alexander B, Desar, Ingrid ME, Boers-Sonderen, Marye J, van Herpen, Carla ML, de Weijert, Mirjam CA, Langenhuijsen, Johan F, Oosterwijk, Egbert, Leenders, William PJ, Boerman, Otto C, Mulders, Peter FA, Oyen, Wim JG

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of metastatic clear cell renal cell carcinoma (RCC). Although TKIs have demonstrated good…”
Get full text

Tyrosine Kinase Inhibitor Sorafenib Decreases sigma up 111 member of n-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma by Muselaers, Constantijn HJ, Stillebroer, Alexander B, Desar, Ingrid ME, Boers-Sonderen, Marye J, van Herpen, Carla ML, de Weijert, Mirjam CA, Langenhuijsen, Johan F, Oosterwijk, Egbert, Leenders, William PJ, Boerman, Otto C, Mulders, Peter FA, Oyen, Wim JG

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of metastatic clear cell renal cell carcinoma (RCC). Although TKIs have demonstrated good…”
Get full text

Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma by Grabmaier, Karin, A de Weijert, Mirjam C, Verhaegh, Gerald W, Schalken, Jack A, Oosterwijk, Egbert

“…Renal cell carcinoma of the clear cell type (ccRCC) is associated with loss of functional von Hippel-Lindau (VHL) protein and high, homogeneous expression of…”
Get full text

Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma by Muselaers, Constantijn H J, Stillebroer, Alexander B, Desar, Ingrid M E, Boers-Sonderen, Marye J, van Herpen, Carla M L, de Weijert, Mirjam C A, Langenhuijsen, Johan F, Oosterwijk, Egbert, Leenders, William P J, Boerman, Otto C, Mulders, Peter F A, Oyen, Wim J G

“…Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of metastatic clear cell renal cell carcinoma (RCC). Although TKIs have demonstrated good…”
Get full text

Strict regulation of CAIXG250/MN by HIF-1[alpha] in clear cell renal cell carcinoma by Grabmaier, Karin, Mirjam CA de Weijert, Verhaegh, Gerald W, Schalken, Jack A, Oosterwijk, Egbert

“…Renal cell carcinoma of the clear cell type (ccRCC) is associated with loss of functional von Hippel-Lindau (VHL) protein and high, homogeneous expression of…”
Get full text

The effect of antibody protein dose of anti‐renal cell carcinoma monoclonal antibodies in nude mice with renal cell carcinoma xenografts by Kranenborg, Marion H. G. C., Boerman, Otto C., Weijert, Mirjam C. A. de, Oosterwijk‐Wakka, Jeannette C., Corstens, Frans H. M., Oosterwijk, Egbert

“…BACKGROUND Antibodies preferentially can direct radionuclides to solid tumors. However, antibody uptake in tumors is often highly heterogeneous. This…”
Get full text

Two‐step radio‐immunotargeting of renal‐cell carcinoma xenografts in nude mice with anti‐renal‐cell‐carcinoma X anti‐DTPA bispecific monoclonal antibodies by Kranenborg, Marion H. G. C., Boerman, Otto C., Oosterwijk‐Wakka, Jeannette C., De Weijert, Mirjam C. A., Corstens, Frans H. M., Oosterwijk, Egbert

“…The specificity of antibodies offers unique opportunities to target tumors with radionuclides. However, due to the slow clearance of radiolabeled antibody,…”
Get full text